The Portland-based biopharmaceutical company has licensed the U.S. rights for Zuplenz, an oral film that contains an anti-nausea medication, ondansetron.
A number of hospitals in the Portland area will be penalized by a federal program which fines hospitals with high rates of infection and other hospital-acquired conditions.
A WalletHub report showed Oregon's coverage rate — the number of people who actually carry insurance — as one of the nation's best.
A $2.3 million settlement has been reached regarding generic drugs made in India.
The Hillsboro-based neighborhood health clinic company received a substantial equity investment from Portland-based investor.